drugset / Trial / NCT02635542

Effect of Neuromuscular Blockade on Pulmonary Complications in Elective Cardiac Surgery

NCT02635542 ↗

Phase 4 Completed 100 enrolled University of Chicago
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigators will conduct a prospective, randomized trial to assess the impact of neuromuscular blockade on early (\<72 hours post-ICU admission) postoperative respiratory complications in cardiac surgical patients. The study will compare continual neuromuscular blockade with cisatracurium to a single dose of succinylcholine during general anesthesia for cardiac surgery.

Timeline

Start
2016-03
Primary completion
2017-09-15
Completion
2017-09-15

Outcome

Missed primary endpoint

registry analysis (superiority test); Group CIS vs Group SUX; p = 1.00; Chi-squared NCT02635542 ↗

registry COUNT_OF_PARTICIPANTS Group CIS: 8 Participants COUNT_OF_PARTICIPANTS Group SUX: 8 Participants NCT02635542 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisatracurium Small molecule 0.2 mg/kg Intravenous
Subject Suxamethonium Other / unclassified 1 mg/kg Intravenous

Indications

No indication recorded.